{"log_id": 8612960937599590219, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0, "average": 0.720798, "min": 0.720798}, "location": {"width": 23, "top": 178, "height": 24, "left": 280}, "words": "三"}, {"probability": {"variance": 0.041578, "average": 0.711886, "min": 0.544614}, "location": {"width": 45, "top": 205, "height": 16, "left": 685}, "words": "600"}, {"probability": {"variance": 4.6e-05, "average": 0.990464, "min": 0.981022}, "location": {"width": 209, "top": 487, "height": 19, "left": 572}, "words": " ME AFTER DOSE"}, {"probability": {"variance": 0, "average": 0.999922, "min": 0.999922}, "location": {"width": 22, "top": 544, "height": 22, "left": 246}, "words": "图"}, {"probability": {"variance": 0.001058, "average": 0.986892, "min": 0.818753}, "location": {"width": 661, "top": 543, "height": 29, "left": 349}, "words": "g,每12小时口服一次,达稳态时利奈唑胺的血浆浓度(平均值±标准差"}, {"probability": {"variance": 0.000247, "average": 0.982192, "min": 0.960178}, "location": {"width": 37, "top": 577, "height": 18, "left": 248}, "words": "=16"}, {"probability": {"variance": 0.001144, "average": 0.989068, "min": 0.796174}, "location": {"width": 737, "top": 604, "height": 27, "left": 284}, "words": "吸收:口服给药后,利奈唑胺吸收快速而完全。给药后约1-2小时达到血浆峰浓度"}, {"probability": {"variance": 0.000146, "average": 0.994387, "min": 0.933742}, "location": {"width": 663, "top": 632, "height": 28, "left": 245}, "words": "绝对生物利用度约为100%。所以,利奈唑胺口服或静脉给药无需调整剂量"}, {"probability": {"variance": 0.000173, "average": 0.993723, "min": 0.929548}, "location": {"width": 756, "top": 663, "height": 28, "left": 285}, "words": "利奈唑胺的给药无须考虑进食的时间。当利奈唑胺与高脂食物同时服用时,达峰时间从"}, {"probability": {"variance": 0.005274, "average": 0.977179, "min": 0.659701}, "location": {"width": 782, "top": 692, "height": 31, "left": 258}, "words": "5小时延迟至2.2小时,峰浓度约下降17%。然而总的暴露量指标AUC0-值在两种情况"}, {"probability": {"variance": 2e-06, "average": 0.99836, "min": 0.995539}, "location": {"width": 100, "top": 724, "height": 23, "left": 247}, "words": "下是相似的"}, {"probability": {"variance": 0.000287, "average": 0.995306, "min": 0.89452}, "location": {"width": 760, "top": 751, "height": 31, "left": 283}, "words": "分布:动物与人的药代动力学研究均证明利奈唑胺能快速地分布于灌注良好的组织。利"}, {"probability": {"variance": 7.2e-05, "average": 0.995475, "min": 0.950471}, "location": {"width": 791, "top": 781, "height": 31, "left": 247}, "words": "奈唑胺的血浆蛋白结合率约为31%且为非浓度依赖性。在健康志愿者中,稳态时利奈唑胺"}, {"probability": {"variance": 0.004144, "average": 0.978085, "min": 0.755935}, "location": {"width": 233, "top": 812, "height": 26, "left": 247}, "words": "的分布容积平均为40—50"}, {"probability": {"variance": 7.7e-05, "average": 0.995727, "min": 0.957318}, "location": {"width": 756, "top": 843, "height": 28, "left": 285}, "words": "在研究利奈唑胺多次给药的I期临床研究中,对有限例数的健康受试者的多种体液中的"}, {"probability": {"variance": 0.008013, "average": 0.981766, "min": 0.417135}, "location": {"width": 794, "top": 872, "height": 29, "left": 247}, "words": "利奈唑胺浓度进行了测定。利奈唑胺在唾液与血浆中的比率为12比1;在汗液与血浆中的"}, {"probability": {"variance": 3e-06, "average": 0.998945, "min": 0.994517}, "location": {"width": 148, "top": 904, "height": 23, "left": 246}, "words": "比率为0.55比1"}, {"probability": {"variance": 0.000416, "average": 0.994636, "min": 0.872879}, "location": {"width": 744, "top": 933, "height": 29, "left": 286}, "words": "代谢:利奈唑胺的主要代谢为吗啉环的氧化,它可产生两个无活性的开环羧酸代谢产物"}, {"probability": {"variance": 0.000271, "average": 0.996305, "min": 0.893667}, "location": {"width": 797, "top": 963, "height": 30, "left": 243}, "words": "氨基乙氧基乙酸代谢物(A)和羟乙基氨基乙酸代谢物(B)。在体外,推测代谢产物A是"}, {"probability": {"variance": 0.001016, "average": 0.990963, "min": 0.811917}, "location": {"width": 795, "top": 995, "height": 27, "left": 246}, "words": "通过一个酶途径形成,而代谢产物B通过非酶介导的化学氧化机制形成。体外研究表明利"}, {"probability": {"variance": 0.000382, "average": 0.992288, "min": 0.885647}, "location": {"width": 796, "top": 1025, "height": 27, "left": 245}, "words": "奈唑胺可能有极低程度的代谢由人类细胞色素酶P450介导。但是,利奈唑胺的代谢途径仍"}, {"probability": {"variance": 0, "average": 0.999302, "min": 0.998651}, "location": {"width": 124, "top": 1052, "height": 28, "left": 245}, "words": "没有完全明确"}, {"probability": {"variance": 0.000176, "average": 0.994415, "min": 0.917785}, "location": {"width": 756, "top": 1084, "height": 28, "left": 286}, "words": "排泄:非肾脏清除率约占利奈唑胺总清除率的65%。稳态时,约有30%的药物以利奈"}, {"probability": {"variance": 2e-05, "average": 0.997096, "min": 0.975037}, "location": {"width": 793, "top": 1116, "height": 25, "left": 247}, "words": "唑胺的形式、40%以代谢产物B的形式、10%以代谢产物A的形式随尿排泄。利奈唑胺的"}, {"probability": {"variance": 0.001531, "average": 0.988011, "min": 0.74233}, "location": {"width": 781, "top": 1146, "height": 26, "left": 246}, "words": "肾脏清除率低(平均为40ml/min),提示有肾小管网的重吸收。事实上,粪便中无利奈唑胺"}, {"probability": {"variance": 0.004616, "average": 0.986895, "min": 0.621048}, "location": {"width": 600, "top": 1176, "height": 26, "left": 248}, "words": "大约有6%和3%的药物分别以代谢产物B和A的形式出现在粪便中"}, {"probability": {"variance": 8e-06, "average": 0.997839, "min": 0.98822}, "location": {"width": 750, "top": 1207, "height": 26, "left": 289}, "words": "随着利奈唑胺剂量的增加,可观察到利奈唑胺轻微的非线性清除,表现为在高浓度时"}, {"probability": {"variance": 0.000159, "average": 0.994178, "min": 0.947019}, "location": {"width": 793, "top": 1236, "height": 27, "left": 248}, "words": "利奈唑胺的肾清除率和非肾清除率降低。然而,清除率的变化很小,不足以影响利奈唑胺的"}, {"probability": {"variance": 2.4e-05, "average": 0.995633, "min": 0.985949}, "location": {"width": 143, "top": 1267, "height": 25, "left": 248}, "words": "表观消除半衰期"}, {"probability": {"variance": 0, "average": 0.999491, "min": 0.999115}, "location": {"width": 81, "top": 1327, "height": 25, "left": 248}, "words": "特殊人群"}, {"probability": {"variance": 5.9e-05, "average": 0.996437, "min": 0.960399}, "location": {"width": 744, "top": 1356, "height": 28, "left": 289}, "words": "老年人:利奈唑胺的药物代谢动力学性质在老年患者(≥65岁)中无显著改变。所以"}, {"probability": {"variance": 4e-06, "average": 0.998605, "min": 0.994187}, "location": {"width": 246, "top": 1388, "height": 26, "left": 247}, "words": "在老年患者中无需剂量调整"}, {"probability": {"variance": 0.001353, "average": 0.989512, "min": 0.769412}, "location": {"width": 758, "top": 1416, "height": 27, "left": 285}, "words": "儿童:在刚出生至17岁的儿童患者(含早产儿及足月出生的新生儿)、12-17岁的健康"}, {"probability": {"variance": 3.8e-05, "average": 0.997797, "min": 0.961199}, "location": {"width": 793, "top": 1449, "height": 26, "left": 248}, "words": "青少年以及出生后1周至12岁的儿童患者中都进行了利奈唑胺单剂量静脉给药的药代动力"}, {"probability": {"variance": 1.1e-05, "average": 0.9975, "min": 0.988879}, "location": {"width": 141, "top": 1479, "height": 23, "left": 576}, "words": "第22页,共25页"}, {"probability": {"variance": 0.00545, "average": 0.961431, "min": 0.734019}, "location": {"width": 96, "top": 1503, "height": 21, "left": 306}, "words": "No:20130823"}], "language": 3}